Contingent Cash Consideration Agreement Sample Contracts

Nupathe Inc. – FORM OF CONTINGENT CASH CONSIDERATION AGREEMENT by and Between TRAIN MERGER SUB, INC., AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent, And, Solely for the Purposes of Section 16, TEVA PHARMACEUTICAL INDUSTRIES LTD. Dated as of [ ], 2014 (January 21st, 2014)

This CONTINGENT CASH CONSIDERATION AGREEMENT (this Agreement), dated as of [ ], 2014, is entered into by and between Train Merger Sub, Inc., a Delaware corporation (the Company) and wholly-owned, indirect subsidiary of the Guarantor (as defined below), American Stock Transfer & Trust Company, LLC, as Paying Agent (the Paying Agent), and, solely for the purposes of Section 16, Teva Pharmaceutical Industries Ltd., an Israeli corporation (the Guarantor).

Nupathe Inc. – FORM OF CONTINGENT CASH CONSIDERATION AGREEMENT by and Between DM MERGER SUB INC., AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent, And, Solely for the Purposes of Section 16, ENDO HEALTH SOLUTIONS INC. (December 16th, 2013)

This CONTINGENT CASH CONSIDERATION AGREEMENT (this Agreement), dated as of [ ], 2014, is entered into by and between DM Merger Sub Inc., a Delaware corporation (the Company) and wholly-owned, indirect subsidiary of the Guarantor (as defined below), American Stock Transfer & Trust Company, LLC, as Paying Agent (the Paying Agent), and, solely for the purposes of Section 16, Endo Health Solutions Inc., a Delaware corporation (the Guarantor).

OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT by and Between ENDO PHARMACEUTICALS HOLDINGS INC. And AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of February 23, 2009 (March 2nd, 2009)

This OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT (this Agreement), dated as of February 23, 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the Company), and American Stock Transfer & Trust Company, as Paying Agent (the Paying Agent).

NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT by and Between ENDO PHARMACEUTICALS HOLDINGS INC. And AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of February 23, 2009 (March 2nd, 2009)

This NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT (this Agreement), dated as of February 23, 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the Company), and American Stock Transfer & Trust Company, as Paying Agent (the Paying Agent).

Indevus Pharmaceuticals Inc. – FORM OF OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT by and Between ENDO PHARMACEUTICALS HOLDINGS INC. And AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of [ ], 2009 (January 6th, 2009)

This OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT (this Agreement), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the Company), and American Stock Transfer & Trust Company, as Paying Agent (the Paying Agent).

Indevus Pharmaceuticals Inc. – FORM OF NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT by and Between ENDO PHARMACEUTICALS HOLDINGS INC. And AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of [ ], 2009 (January 6th, 2009)

This NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT (this Agreement), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the Company), and American Stock Transfer & Trust Company, as Paying Agent (the Paying Agent).

FORM OF OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT by and Between ENDO PHARMACEUTICALS HOLDINGS INC. And AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of [ ], 2009 (January 5th, 2009)

This OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT (this "Agreement"), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company"), and American Stock Transfer & Trust Company, as Paying Agent (the "Paying Agent").

FORM OF OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT by and Between ENDO PHARMACEUTICALS HOLDINGS INC. And AMERICAN STOCK TRANSFER & TRUST COMPANY as Paying Agent Dated as of [ ], 2009 (January 5th, 2009)

This OCTREOTIDE CONTINGENT CASH CONSIDERATION AGREEMENT (this "Agreement"), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company"), and American Stock Transfer & Trust Company, as Paying Agent (the "Paying Agent").

FORM OF NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT by and Between (January 5th, 2009)

This NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT (this "Agreement"), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company"), and American Stock Transfer & Trust Company, as Paying Agent (the "Paying Agent").

FORM OF NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT by and Between (January 5th, 2009)

This NEBIDO CONTINGENT CASH CONSIDERATION AGREEMENT (this "Agreement"), dated as of [ ], 2009, is entered into by and between Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company"), and American Stock Transfer & Trust Company, as Paying Agent (the "Paying Agent").